NERV vs SRZN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

NERV

32.7
AI Score
VS
NERV Wins

SRZN

29.5
AI Score

Investment Advisor Scores

NERV

33score
Recommendation
SELL

SRZN

30score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NERV SRZN Winner
Net Income -8.80M -207.05M NERV
Operating Income -7.51M -38.47M NERV
ROE -19.4% 61.7% SRZN
ROA -7.9% -189.9% NERV
Total Assets 111.83M 109.03M NERV
Cash 80.14M 100.35M SRZN
Current Ratio 24.32 7.56 NERV

Relative Price Performance (Last 90 Days)

NERV 1M: +1.8% · 3M: -34.7% SRZN 1M: +35.6% · 3M: +34.3%

Current Technical Phase

NERV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $2.56

SRZN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 61

RSI (14): 60.5 · Price: $31.88

Fundamentals Snapshot

Metric NERV SRZN
Market Cap — —
Forward P/E -6.1 -7.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 4.1%
Gross Margin — -2.6%
Operating Margin 0.0% -4.9%
EPS -33.83 -41.94
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NERV is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.